Michael Gower
Psychiatry · Lakewood, CONPI 1265660104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 298 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,735 and has fallen 61.6% since, to $1,051 in 2024. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Tris Pharma Inc$775
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$568
- Otsuka America Pharmaceutical, Inc.$417
- Supernus Pharmaceuticals, Inc.$331
- Ironshore Pharmaceuticals Inc.$309
- plus $3K from 18 others
What the payments were for
- Food & beverage$6,030100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,068 |
| Tris Pharma Inc | 13 | $775 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $568 |
| Otsuka America Pharmaceutical, Inc. | 36 | $417 |
| Supernus Pharmaceuticals, Inc. | 11 | $331 |
| Ironshore Pharmaceuticals Inc. | 19 | $309 |
| Alkermes, Inc. | 16 | $303 |
| Teva Pharmaceuticals USA, Inc. | 10 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $292 |
| Neurocrine Biosciences, Inc. | 11 | $229 |
| Lundbeck LLC | 12 | $215 |
| Corium, LLC | 10 | $184 |
| Sunovion Pharmaceuticals Inc. | 12 | $157 |
| Idorsia Pharmaceuticals US Inc | 9 | $152 |
| Vanda Pharmaceuticals Inc. | 7 | $149 |
| Eisai Inc. | 8 | $129 |
| AstraZeneca | 1 | $103 |
| Axsome Therapeutics, Inc. | 5 | $87 |
| Bausch Health US, LLC | 4 | $86 |
| Johnson & Johnson | 4 | $78 |
| Almatica Pharma LLC | 2 | $30 |
| Biogen | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$157
- Dyanavel XR$111
- FARXIGA$103
How this compares
$6,030 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 13 | $5,716 |
| Bupropion XlBupropion Hcl | 17 | $418 |
| Trazodone Hcl | 11 | $276 |
| Clonazepam | 34 | $223 |
| Lamotrigine | 15 | $217 |
| Mirtazapine | 12 | $161 |
| Topiramate | 22 | $101 |
| Escitalopram Oxalate | 21 | $64 |
| Clonidine Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lakewood
- Jordan SuchyLakewood$3K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.